The inaugural AACR Drug Discovery and Development (AACR D3) meeting will convene experts to reshape the future of oncology...
After being diagnosed with cancer, some patients consider getting a second opinion. This may involve a pathologist confirming a...
Hospice care and palliative care share similar goals in providing relief of pain and other symptoms, but they remain...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
At the end of last week, the U.S. Food and Drug Administration (FDA) announced the approval of the first...
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer...
On Thursday, the U.S. Food and Drug Administration (FDA) expanded the use of the antiangiogenic therapeutic regorafenib (Stivarga) to...
The U.S. Preventive Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55...
The American Association for Cancer Research (AACR) Annual Meeting 2017 brought some of the world’s greatest scientific minds to...